What did TRUSCREEN GROUP LIMITED announce?
TRUSCREEN GROUP LIMITED (NZX: TRU) filed “TruScreen Shareholder Update” with NZX on 11 October 2026, as an operational update announcement.
- Which company?
- TRUSCREEN GROUP LIMITED (NZX: TRU)
- When was it filed?
- 11 October 2026
- Where is the original?
- NZX announcement
TruScreen Shareholder Update
TRUSCREEN.COM
truscreen.com
BEYOND
SCREENING
TruScreen’s news from
around the globe
OCTOBER 2026
Follow us: Get in touch: info@truscreen.com
TRUSCREEN FEATURED AT WHO CO-HOSTED
AFRICA HEALTH CARE SUMMIT
Summit hosted in Rwanda and co-hosted by the World Health Organisation
(WHO), Africa Centres for Disease Control and Prevention (Africa CD) and Smart
Africa
TruScreen’s Rwandan representative, Charles Nshimiyimana of Biotech Medical
Supply (BMS) was invited to present TruScreen at the Cervical Cancer plenary session
of the Africa Health Tech Summit held in Kigali from 30 Sep-2 Oct. The summit brought
together more than 4,000 delegates from across Africa and beyond, including
government leaders, health professionals, technology innovators, investors and key
Non Government and Government organisations including WHO and Africa CDC, and
Ministry of Health officials from across Africa.
As well as presenting at the Plenary Session, Charles met the Rwanda Minster of
Health Dr Sabin Nzanzimana and discussed TruScreen with him. The Minister has
arranged for two key Medical Advisors from his department to introduce TruScreen to
their Expert Panel, and BMS is also organizing a meeting with Rwanda Biomedical
Centre (RBC), the organization that implements the public health programs of
Rwanda.
TRUSCREEN.COM
truscreen.com
TruScreen CEO Keynote Speaker at inaugural Kenya-Australia
Trade and Investment Summit
TruScreen African Footprint Expanded with Appointment of
Distributor for Kenya, Somalia and South Sudan
On 11 September, TruScreen CEO Marty Dillon was an invited keynote
speaker at the Inaugural Kenya-Australia Trade and Investment Summit
in Sydney. Guests included the Kenya High Commissioner, Federal and
NSW cabinet members, business and academic leaders and members of
the Kenyan Community - including the Hon Bishop Jackson Kipkemoi
Kosgei MP (Head of Delegation) and Hon Beatrice Chepng’eno Kemei MP
who has a mandate that includes advocacy on gender equality, youth,
children, social protection and community-development.
Following quickly from the Summit, TruScreen expanded its African
footprint with the appointment of Ansell Pharmaceuticals Limited as our
distributor for Kenya, Somalia and South Sudan. Ansell’s 25 member
team is experienced in the supply of pharmaceuticals and medical
devices to NGOs, including WHO and the UN, for NGO funded public
health programs in East Africa.
EAST AFRICA
ZIMBABWE
OCTOBER 2026
Follow us: Get in touch: info@truscreen.com
TruScreen is still under consideration for several major grants and programs. The largest of these are the Clinton Health Access Initiative
application covering Sub-Saharan Africa and the UNITAID application (championed by a leading African NGO) also for Sub-Saharan Africa. In
addition TruScreen is awaiting the outcome of a Nigeria-specific application for the Beginning Investigator Grant for Catalytic Research (BIG Cat),
supported by American Association for Cancer Research, submitted by Dr Ayokunle Olumodeji from Lagos State University Teaching Hospital
who is assisting in the preparation of applications for two more grants for programs in Nigeria.
L-R: Associate Professor David Mickler, Curtin University; His Excellency
Ambassador Dr Wilson Kogo, Kenya High Commissioner to Australia;Hon.
Anoulack Chanthivong, MP, Minister for Industry and Trade, Minister for
Innovation, Science and Technology, NSW; Marty Dillon
L-R: Marlene Ayiro, Principal Legal Counsel – Kenya National Assembly;
Timothy Kipchumba Toroitich MP Marakwet West Constituency; Beatrice
Chepngeno Kemei MP, Woman Representative Kericho County; Marty
Dillon; Ruth Nduta Kamau, Organising Committee
Following much bureaucratic wrangling, the year’s first
screening program for 10,800 women in Masvingo
Province is expected to commence in 16 public
hospitals in November 2026, with a second program
already in discussion with our distributor.
AFRICAN GRANT APPLICATIONS
NEWS FROM AROUND THE GLOBE....
TRUSCREEN.COM
truscreen.com
OCTOBER 2026
Follow us: Get in touch: info@truscreen.com
China’s South and West China Rollout Strategy begins
TruScreen’s China distributor, SiWeiXaingTai Technology (SWXT) has commenced a
major campaign to bring TruScreen to key Southern and Western markets. Especially
important is their focus on Sichuan province which now serves as the national role model
for Gynaecological products inclusion in national public hospital catalogues. The lead
gynaecologist in Sichuan province is a significant supporter of TruScreen and was
involved in the landmark COGA study which demonstrated TruScreen’s superiority as a
cervical cancer screening technology. The West China Second University Hospital of
Sichuan University, the most prominent gynaecology centre in Sichuan and one of the
best OBGYN hospitals in the country, is preparing a formal submission for TruScreen to
be included in the public hospital catalogue.
In the South, Guangdong Province is the most important market for TruScreen’s growth.
In October, our distributor SWXT will sponsor the key OBGYN conference in Shantou City,
and one of the major hospitals in the province, The Third Affiliated Hospital, Sun Yat-sen
University, will start a clinical study on TruScreen involving 500 women. SWXT’s activities
are bearing fruit as two new hospitals have recently received approval to install
TruScreen and a further two key hospitals have applied for and are awaiting approval to
install TruScreen.
In the North in Jilin Province, TruScreen has been included in the provincial hospital
catalogue and attained pricing approval. This will support the Sichuan application by
acting as another strong reference for national catalogue inclusion, which will accelerate
TruScreen’s national roll out in China.
CHINA
TruScreen’s clinical validation program in Tashkent
has been completed and preliminary results have
been reported as ‘very good’. Final publication of
the results will clear the path for public health
adoption of TruScreen in Uzbekistan.
Following this news Albatros Health Care LLC,
TruScreen’s distributor in Uzbekistan has placed
their first order of 2,160 SUS, to be delivered this
month.
UZBEKISTAN
NEWS FROM AROUND THE GLOBE....
In addition to the Shariaptur Development Society grant application
featured in our last newsletter, TruScreen’s local distributor in Bangladesh -
Xerox Medica Ltd - has engaged in talks with the Bangladesh Ministry of
Health regarding additional programs utilising TruScreen’s unique AI
enabled technology. The proposed projects will be funded by the
Bangladesh government and NGO’s including the World Bank and the Asia
Development Bank.
Nova Biointermedicx Pvt Ltd has been appointed as the TruScreen
distributor for Nepal. Nova Biointermedicx has extensive connections across
Nepal’s Central and Provincial governments. Nova selected TruScreen as
their preferred technology after comparing TruScreen to competitors for
cervical cancer screening available on the local market, and chose
TruScreen to participate in the upcoming government tender which opens in
November. Nova is adamant that TruScreen offers the ideal solution to the
problems in cervical cancer screening in Nepal where the government is
striving to achieve the 70% screening coverage goal committed with WHO.
A cohesive strategic approach is being developed for TruScreen
expansion across the Indian subcontinent, with TruScreen
executive Sumaya Mozumder taking on the role of TruScreen’s
dedicated regional account manager. We have been working with
Austrade to build key relationships in the region with our Indian
distributor, Renovate Biologicals, as well as exploring collaborative
opportunities with major NGOs including PATH (Program for
Appropriate Technologies in Health) in India. Indian product
registration is expected to be obtained in October or November,
with our distributor Renovate Biologicals preparing for an imminent
product launch in the worlds most populous country and fourth
largest economy
OCTOBER 2026
NEWS FROM AROUND THE GLOBE....
Follow us:
truscreen.com
Get in touch: info@truscreen.com
INDIAN SUBCONTINENT EXPANSION
BANGLADESH
NEPAL
TruScreen has saved over
72,000* lives - enough to fill an
international football stadium.
Dr Carolina Velasquez holds a Bachelor of Medicine and Surgery
from Pontificia Universidad in Colombia and a Masters in Clinical
Research from Monash University in Melbourne.
Multi lingual, she has 8 years experience with TruScreen
conducting and supervising clinical trials in Australia, India,
Zimbabwe, China, Vietnam, Indonesia and Mexico as well as
overseeing all TruScreen user training across the globe.
Dr Velasquez also co-ordinates the work of both Truscreen's
Medical Advisory Committee and international Medical Experts
Group.
That’s the number of women who have received
an abnormal TruScreen result and been referred
for triage or treatment before their disease could
silently progress to cancer.
*based on an average global abnormality rate of 6%.
Learn more about:
Dr Carolina Velasquez MBBS, M ClinRes
TruScreen’s Medical Affairs and Training Manager
NEWS FROM HQ...
truscreen.com
DID YOU KNOW?
OCTOBER 2026
Follow us: Get in touch: info@truscreen.com
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.